10 Best Consumer Service Stocks To Own For 2014

Japanese stocks rose, with the Topix (TPX) Index paring a weekly loss, as Tokyo Electron Ltd. (8035) led chip-equipment makers higher and exporters rebounded after Finance Minister Taro Aso said global policy makers wouldn�� censure Japan for the currency�� slide.

Toyota Motor Corp. (7203), Japan�� biggest company, added 0.6 percent. Tokyo Electron climbed 7.1 percent after topping estimates for operating profit. Capcom Co. jumped 9 percent after saying it will buy back shares.

The Topix gained 0.3 percent to close at 1,126.67 in Tokyo, capping a 1.9 percent weekly drop, the most since November. The Nikkei 225 Stock Average rose 0.7 percent to 13,316.48, rebounding from a 0.3 percent drop, as the yen weakened against all 16 of its major peers. Canon Inc. and Nintendo Co. are among more than 200 companies on the 1,698-member Topix (NKY) due to report earnings next week, according to data compiled by Bloomberg.

��ow that investors see the yen isn�� going to rise, stocks are rebounding,��said Isao Kubo, a Tokyo-based equity strategist at Nissay Asset Management Corp., which oversees the equivalent of about $51 billion. ��here are expectations companies will report strong earnings on the back of government policy and a weaker yen.��

Top 10 Warren Buffett Companies To Invest In Right Now: iShares Core S&P Small-Cap ETF (IJR)

iShares Core S&P Small-Cap ETF, formerly iShares S&P SmallCap 600 Index Fund, seeks investment results that correspond generally to the price and yield performance of the Standard & Poor's SmallCap 600 Index (the Index). The Index measures the performance of publicly traded securities in the small-capitalization sector of the United States equity market. The Index serves as the underlying index for the S&P 600/Citigroup Growth and Value Index series. The component stocks are weighted according to the total float-adjusted market value of their outstanding shares. The component stocks in the Index have a market capitalization between $300 million and $1 billion (which may fluctuate depending on the overall level of the equity markets), and are selected for liquidity and industry group representation. The Index is adjusted to reflect changes in capitalization resulting from mergers, acquisition, stock rights, substitutions and other capital events.

The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. iShares S&P SmallCap 600 Index Fund�� investment advisor is Barclays Global Fund Advisors.

Advisors' Opinion:

• [By Chris Ciovacco]

  In Thursday's ETF analysis, evidence is presented that supports increasing demand for assets that get a tailwind from a weak U.S. dollar, including emerging markets (EEM) and foreign stocks (EFA). Casting a wider economic net, our market model told us to start buying stocks last week even with the threat of a U.S. default. Wednesday, we continued with our incremental allocation shifts by adding some exposure to the energy sector. Thursday, we sat tight holding long positions in small caps (IJR), Europe (FEZ), emerging markets and technology (QQQ). The upper bounds of the bullish S&P 500 trend channel shown below may offer some resistance to the market's near vertical ascent.

• [By Tom Aspray]

  I still think the emerging markets may be the surprise in 2014 as the technical outlook has improved but a bottom has not yet been confirmed. The more active investor should consider investing in several index-tracking ETFs, but in volatile areas, like the emerging markets, the percentage commitment should be kept low. One should consider not only the large-cap S&P 500 but also the small-cap sectors like iShares S&P 600 Small-Cap (IJR), which I recommended last Wednesday.

• [By John Udovich]

  One of the most famous scenes in the cult classic, the Graduate, was when Mr. McGuire�took Dustin Hoffman�� character aside and said�"Ben, I want to say one word to you, just one word: Plastics"; but what about the Berry Plastics Group Inc (NYSE: BERY) and its performance verses that of the�iShares S&P 500 Index ETF (NYSEARCA: IVV), iShares Russell Midcap Index Fund ETF (NYSEARCA: IWR) and iShares S&P SmallCap 600 Index ETF (NYSEARCA: IJR)? I should mention that plastics and the Berry Plastics Group was not the place to be yesterday as the stock took a tumble on reduced guidance.

10 Best Consumer Service Stocks To Own For 2014: Charter Financial Corp.(CHFN)

Charter Financial Corporation operates as the holding company for CharterBank that provides various banking services to individuals and businesses in Georgia and Alabama. Its deposit products include demand, NOW, and money market accounts; savings deposits; time deposits; checking accounts; and certificates of deposit. The company's loan products comprise commercial real estate loans; one- to four-family residential mortgage loans; construction and development loans; commercial business loans; and consumer loans, such as home equity loans, lines of credit, auto loans, and second mortgage loans. It operates through 16 branch offices located in West Point, LaGrange, Newnan, Carrollton, Bremen, Covington, and Peachtree City, Georgia; and Auburn, Opelika, and Valley, Alabama, as well as through a loan production office located in Norcross, Georgia. The company was founded in 1954 and is based in West Point, Georgia. Charter Financial Corporation operates as a subsidiary of Fir st Charter, MHC.

Advisors' Opinion:

• [By Tim Melvin]

  I get somewhat amused every day by the thousands of traders who spend all day trying to figure out what the hot stocks like Twitter (TWTR) and Facebook (FB) are going to do every day. Owning stocks like these two banks — or ones I have mentioned before, like ESSA Bancorp (ESSA) and Charter Financial (CHFN) — will be a far more profitable and relaxing endeavor over the next few years.

10 Best Consumer Service Stocks To Own For 2014: Galena Biopharma Inc (GALE)

Galena Biopharma, Inc. (Galena), formerly RXi Pharmaceuticals Corporation, incorporated on April 3, 2006, is a biotechnology company focused on discovering, developing and commercializing therapies addressing unmet medical needs using targeted biotherapeutics. The Company is pursuing the development of cancer therapeutics using peptide-based immunotherapy products, including its main product candidate, NeuVaxTM (E75), for the treatment of breast cancer and other tumors. NeuVax is a peptide-based immunotherapy intended to reduce the recurrence of breast cancer in low-to-intermediate HER2-positive breast cancer patients not eligible for trastuzumab (Herceptin; Genentech/Roche). On January 19, 2012, the Company initiated enrollment in its Phase 3 PRESENT clinical trial for NeuVax (E75 peptide plus GM-CSF) vaccine in low-to-intermediate HER2 1+ and 2+ breast cancer patients in the adjuvant setting to prevent recurrence (Clinicaltrials.gov identifier NCT01479244). The Prevention of Recurrence in Early-Stage, Node-Positive Breast Cancer with Low to Intermediate HER2 Expression with NeuVax Treatment study is a randomized, multicenter, multinational clinical trial that will enroll approximately 700 breast cancer patients. The Company�� Phase 2 trial of NeuVax achieved its primary endpoint of disease-free survival (DFS). On April 13, 2011, the Company completed its acquisition of Apthera, Inc.,(Apthera).

The Company focuses to start a Phase 2 trial comparing NeuVax in combination with trastuzumab (Herceptin) versus trastuzumab, alone, in a 300-patient, randomized study in the adjuvant breast cancer setting. The Company's second product candidate, Folate Binding Protein-E39 (FBP), is a vaccine, consisting of the peptides E39 and J65, aimed at preventing the recurrence of ovarian, endometrial, and breast cancers. On February 14, 2012, the Company announced the initiation of a Phase 1/2 clinical trial in two gynecological cancers: ovarian and endometrial adenocarcinomas. Folate binding protein has ! very limited tissue distribution and expression in non-malignant tissue and is over-expressed in more than 90% of ovarian and endometrial cancers, as well as in 20% to 50% of breast, lung, colorectal and renal cell carcinomas.

In April 2011, the Company acquired Apthera Inc and its NeuVax product candidate. The Company focuses on developing a pipeline of immunotherapy product candidates for the treatment of various cancers based on the E75 peptide, the advanced of which is NeuVax, which is targeted at preventing the recurrence of breast cancer. NeuVax has had positive Phase 1/2 clinical trial results for the prevention of breast cancer recurrence in patients who have had breast cancer and received the standard of care treatment (surgery, chemotherapy, radiotherapy and hormonal therapy as indicated). The Company had also initiated its Phase 3 PRESENT clinical trial of NeuVax for the prevention of breast cancer recurrence in early-stage low-to-intermediate HER2 breast cancer patients. NeuVax directs killer T-cells to target and destroy cancer cells that express HER2/neu, a protein associated with epithelial tumors in breast, ovarian, pancreatic, colon, bladder and prostate cancers. NeuVax is comprised of a HER2/neu-derived peptide called E75. E75 is a nine-amino acid sequence that is immunogenic (produces an immune response) and GM-CSF is a commercially available protein that acts to stimulate and activate components of the immune system such as macrophages and dendritic cells.

The Company also develops novel applications for NeuVax based on preclinical studies and phases 2 clinical trials which suggest that combining NeuVax and trastuzumab (Herceptin; Genentech/Roche) can increase antigen presentation by tumor cells by promoting receptor internalization and subsequent proteosomal degradation of the HER2 protein. The Company also is pursuing additional therapeutic indications for NeuVax that are in Phase 1/2 clinical trials. RXI-109, is a dermal anti-scarring therapy that targets! connecti! ve tissue growth factor (CTGF) and that may inhibit connective tissue formation in human fibrotic disease.

The Company competes with Roche Laboratories, Inc., Pfizer Inc., Bayer HealthCare AG, Sanofi-Aventis, US, LLC, Amgen, Inc., GlaxoSmithKline plc, Renovo Group plc, CoDa Therapeutics, Inc., Sirnaomics, Inc., FirstString Research, Inc., Merz Pharmaceuticals, LLC, Capstone Therapeutics, Halscion, Inc., Garnet Bio Therapeutics, Inc., AkPharma Inc., Promedior, Inc., Kissei Pharmaceutical Co., Ltd., Eyegene, Derma Sciences, Inc., Healthpoint Biotherapeutics, Pharmaxon, Excaliard Pharmaceuticals, Inc., Alnylam Pharmaceuticals, Inc., Marina Biotech, Inc., Tacere Therapeutics, Inc., Benitec Limited, OPKO Health, Inc., Silence Therapeutics plc, Quark Pharmaceuticals, Inc., Rosetta Genomics Ltd., Lorus Therapeutics, Inc., Tekmira Pharmaceuticals Corporation, Arrowhead Research Corporation, Regulus Therapeutics Inc. and Santaris.

Advisors' Opinion:

• [By James E. Brumley]

  The last two weeks have been absolutely fantastic ones for Galena Biopharma Inc. (NASDAQ:GALE). Shares have soared from $2.37 to the current price of $3.32 - a 40% pop - rewarding investors who had been patiently waiting through late October for the runup to take hold. Congratulations if that's you. But, if that was you, then now might be a great time to take the money and run with the trade, as GALE looks poised to make a sizeable pullback. More on that in a moment.

• [By Paul Ausick]

  Stocks on the move: Galena Biopharma Inc. (NASDAQ: GALE) is down 15.4% at $1.93 after pricing a secondary offering of 17.5 million units at $2.00. Safeway Inc. (NYSE: SWY) is up 6.1% at $28.21, after an analyst�� upgrade which sent shares to a new 52-week high of $28.88 earlier. Avanir Pharmaceuticals Inc. (NASDAQ: AVNR) is down 18.2% at $4.08.

10 Best Consumer Service Stocks To Own For 2014: W.P. Carey & Co. LLC(WPC)

W. P. Carey & Co. LLC, together with its subsidiaries, provides long-term sale-leaseback and build-to-suit transactions for companies worldwide and manages a global investment portfolio. It invests primarily in commercial properties that are each triple-net leased to single corporate tenants, which requires each tenant to pay substantially all of the costs associated with operating and maintaining the property. The company also operates as an advisor to publicly owned, non-actively traded real estate investment trusts, which are sponsored by it under the Corporate Property Associates brand name, as well as invests in similar properties. As of March 31, 2010, its portfolio comprised full or partial ownership interest in 167 properties that totaled approximately 14 million square feet. W. P. Carey & Co. LLC was founded in 1973 and is based in New York, New York.

Advisors' Opinion:

• [By Shauna O'Brien]

  Real estate investment trust W.P. Carey Inc. (WPC) announced on Tuesday that it has acquired an UK government office facility for $72 million.

  WPC has acquired an office facility from the Department of State for Communities and Local Government (DCLG) located in Manchester, UK. This office is leased to the DCLG on a 15 year triple net lease and is currently occupied by the UK’s tax department.

  Jennifer Lucas, Director of WPC commented: “The recent staff consolidation into the facility demonstrates that this is an important location for HMRC and supports our proven business model of acquiring key operating assets let to single tenants on long-term net-leases.”

  W.P. Carey shares were mostly flat during pre-market trading Tuesday. The stock is up 27% YTD.

• [By Dividends4Life]

  W. P. Carey Inc. (WPC) is an independent equity real estate investment trust. The firm also provides long-term sale-leaseback and build-to-suit financing for companies. September 19th the company increased its quarterly dividend 2.4% to $0.86 per share. The dividend is payable October 15, 2013 to stockholders of record as of September 30, 2013. The yield based on the new payout is 5.2%.

• [By David Dittman]

  Answer: Realty Income Corp (NYSE: O) and WP Carey & Co (NYSE: WPC), up to 45 and 55, respectively.

  Question: Bell Alliant Inc (TSX: BA, OTC: BLIAF) has been weak/flat even though the overall market has been strong. Great dividend; is it solid? Is it worth continuing to hold?

10 Best Consumer Service Stocks To Own For 2014: Standard Pacific Corp(SPF)

Standard Pacific Corp. operates as a diversified builder of single-family attached and detached homes in the United States. It constructs homes targeting various homebuyers primarily move-up buyers in metropolitan markets in California, Florida, the Carolinas, Texas, Arizona, Colorado, and Nevada. The company also provides mortgage financing services to its homebuyers; and title examination services to its Texas homebuyers. As of December 31, 2011, it owned or controlled 26,444 homesites and had 166 active selling communities. Standard Pacific Corp. was founded in 1965 and is headquartered in Irvine, California.

Advisors' Opinion:

• [By Erika Janowicz]

  Compass Point analyst Wilkes Graham updated his housing forecast:

  Graham increased assumed ROI's to 9% on average from 7%. Reduced targeted sector price/ book from $190% to 170%. Expects 20-30% growth in starts and new home sales in 2012 and 2013 to stabilize in 2014 and on at approximately 10%. For covered builders, the analyst lowered estimates by 8% and lowered price targets by 10%. Compass Point expects 10% annual growth in single family starts and new home sales and 2-5% pricing growth. Downgraded DR Horton Inc. (NYSE: DHI) from Buy to Neutral and KB Home (NYSE: KBH) from Neutral to Sell. DR Horton's and KB Home's PT was lowered from $23.50 to $20.00 and from $17.50 to $14.00, respectively. Graham reiterated a Buy rating on Ryland Group Inc. (NYSE: RYL) and Standard Pacific Corp. (NYSE: SPF). The analyst raised the PT on Ryland from $50.00 to $50.50 and lowered the PT on Standard Pacific from $10.00 to $9.50. Compass Point reiterated a Neutral rating on Beazer Homes USA Inc. (NYSE: BZH), Hovnanian Enterprises Inc. (NYSE: HOV), Lennar Corp. (NYSE: LEN), PulteGroup, Inc. (NYSE: PHM), and Toll Brothers Inc. (NYSE: TOL). The price target for Beazer and Hovnanian was raised from $15.50 to $24.00 and $5.00 to $5.75, respectively. Graham lowered the PT for Lennar, Pulte, and Toll to $34.50, $17.00, and $31.00.

  This Week's Data

• [By Louis Navellier]

  If we look at those stocks trading with single-digit P/E ratios right now, it becomes a very simple task to separate the wheat from the chaff. There are many well-known stocks trading at low P/E ratios that get horrible grades from our system and should be avoided:

  Ryland Homes (RYL) is a name you might hear discussed as a bargain, but the stock to a Sell back in November to a ����and is best avoided. Standard Pacific (SPF) is another builder you should probably avoid as In spite of the low P/E ratio ,you probably want to avoid discount retailer Big Lots (BIG), as a Strong Sell this week.

  But fear not — there are some great companies with solid fundamentals that earn a Buy ranking from Portfolio Grader and are better candidates for a low-P/E portfolio.

10 Best Consumer Service Stocks To Own For 2014: BAB Inc (BABB)

BAB, Inc., incorporated on July 12, 2000, franchises and licenses bagel and muffin retail units under the Big Apple Bagel (BAB) and My Favorite Muffin (MFM) trade names. At November 30, 2012, the Company had 100 franchise units and 6 licensed units in operation in 24 states. The Company additionally derives income from the sale of its trademark bagels, muffins and coffee through nontraditional channels of distribution including under licensing agreements with Kohr Bros. Frozen Custard, Kaleidoscoops, Green Beans Coffee, Sodexo and through direct home delivery of specialty muffin gift baskets and coffee. The Company has two wholly owned subsidiaries: BAB Systems, Inc. (Systems) and BAB Operations, Inc. (Operations). At November 30, 2012, the Company had 100 franchise units and six licensed units in operation in 24 states.

The Company additionally derives income from the sale of its trademark bagels, muffins and coffee through nontraditional channels of distribution including under licensing agreements with Kohr Bros. Frozen Custard, Kaleidoscoops, Green Beans Coffee, Sodexo and through direct home delivery of specialty muffin gift baskets and coffee. The BAB franchised brand consists of units operating as Big Apple Bagels, featuring daily baked bagels, flavored cream cheeses, premium coffees, gourmet bagel sandwiches and other related products. Licensed BAB units serve the Company's par-baked frozen bagel and related products baked daily. BAB units are primarily concentrated in the Midwest and Western United States. The MFM brand consists of units operating as My Favorite Muffin, featuring a variety of freshly baked muffins, coffees and related products, and units operating as My Favorite Muffin and Bagel Cafe, featuring these products as well as a variety of specialty bagel sandwiches and related products.

The Company�� BAB offering franchises in all 50 states, its initial development focus is targeted for the Midwest, specifically Illinois, Michigan, Wisconsin and Ohio. A! s part of its introductory development plan, BAB will be donating 10% of the initial franchise fee from its 50 SweetDuet units to the Cystic Fibrosis Foundation, of which BAB is a corporate sponsor. SweetDuet, as its name implies, is a fusion concept, pairing self-serve frozen yogurt with BAB's exclusive line of My Favorite Muffin gourmet muffins, broadening the shop's offering and therefore differentiating itself from the numerous frozen yogurt outlets already populating the market. SweetDuet shops include BAB's Brewster's Coffee and a streamlined breakfast menu. The concept is designed to work in 1600 square feet of space.

BAB franchised stores daily bake a variety of fresh bagels and offer up to 11 varieties of cream cheese spreads. Stores also offer a variety of breakfast and lunch bagel sandwiches, salads, soups, various dessert items, fruit smoothies, gourmet coffees and other beverages. A typical BAB store is in an area with a mix of both residential and commercial properties and ranges from 1,500 to 2,000 square feet. The Company's current store design is approximately 1,800 square feet, with seating capacity for 20 to 30 persons, and includes approximately 750 square feet devoted to production and baking. A satellite store is typically smaller than a production store, averaging 800 to 1,200 square feet. Although franchise stores may vary in size from other franchise stores, store layout is generally consistent.

MFM franchised stores daily bake 20 to 25 varieties of muffins from over 250 recipes, plus a variety of bagels. They also serve gourmet coffees, beverages and, at My Favorite Muffin and Bagel Cafe locations, a variety of bagel sandwiches and related products. The typical MFM store design is approximately 1,800 square feet, with seating capacity for 20 to 30 persons.The Company advertises its franchising opportunities in directories, newspapers and the Internet.

The Company competes with Einstein Noah Restaurant Group, Panera Bread Company and Brue! gger's Ba! gel Bakery.

Advisors' Opinion:

• [By CRWE]

  Today, BABB remains (0.00%) +0.000 at $.800 thus far (ref. google finance July 11, 2013).

  For the quarter ended May 31, 2013, BAB had revenues of $658,000 and net income of $125,000, or $0.02 per share, versus revenues of $826,000 and net income of $267,000, or $0.04 per share, for the same quarter last year. For the quarter ended May 31, 2012, the Company received a $171,000 payment for the buyout of the Franchise Agreement from its Minot, ND franchisee so the franchisee could pursue its other business interests associated with the local energy boom. In that acceptance by the Company of the voluntary buyout is unique, no such transaction occurred nor was such income earned in the quarter ended May 31, 2013.

10 Best Consumer Service Stocks To Own For 2014: QLogic Corporation(QLGC)

QLogic Corporation engages in the design and supply of storage networking, high performance computing networking, and converged networking infrastructure solutions. It offers various host products, including fiber channel and Internet small computer systems interface (iSCSI) host bus adapters; fiber channel over Ethernet (FCoE) converged network adapters; and intelligent Ethernet adapters. The company also provides network products, which consist of fiber channel switches, including stackable edge switches, bladed switches, virtualized pass-through modules, and high-port count modular-chassis switches; Ethernet pass-through modules; and storage routers for bridging fiber Channel, FCoE, and iSCSI networks, as well as for migrating data between storage devices. In addition, it offers silicon products comprising fiber channel, iSCSI, converged network, and Ethernet controllers. Further, the company involves in the design and development of application-specific integrated circ uits, adapters, and switches based on fiber channel, iSCSI, FCoE, and Ethernet technologies. Its products are used in server, workstation, and storage subsystem solutions that are used by small, medium, and large enterprises with various business data requirements. The company sells its products to original equipment manufacturers and distributors worldwide. QLogic Corporation was founded in 1992 and is headquartered in Aliso Viejo, California.

Advisors' Opinion:

• [By Sean Williams]

  Shareholders in networking equipment maker QLogic (NASDAQ: QLGC  ) certainly have a reason to rejoice, as it will be added to the S&P Small Cap 600 as of the close of business on Friday. Being added to the S&P Small Cap 600 index will mean that mutual funds that track the index will be required to purchase shares of QLogic. With more than $5 in cash per share on its balance sheet, the downside risk in QLogic is quickly abating.

• [By Sean Williams]

  This week's loser
  On the other side of the coin was networking equipment maker QLogic (NASDAQ: QLGC  ) , which tanked 4.8% on the week after disclosing that its CEO, Simon Biddiscombe, had resigned on Friday. In the interim, QLogic's CFO, Jean Hu, will be the acting CEO. Anytime the management of a company changes, it provides a level of uncertainty that's bound to unnerve investors. I'd urge current shareholders (of which I'm one) to remember that QLogic has been consistently profitable for years, has $5 in net cash per share, and is poised to benefit from higher infrastructure spending. Patience will pay off here!